How to buy Nanobiotix S-A (NBTX) stock

Nanobiotix S.A is a biotechnology business based in the US. Nanobiotix S-A shares (NBTX) are listed on the NASDAQ and all prices are listed in US Dollars. Nanobiotix S-A employs 88 staff and has a trailing 12-month revenue of around 0.00.

Nanobiotix S-A stock price (NASDAQ: NBTX)

Use our graph to track the performance of NBTX stocks over time.

Nanobiotix S-A shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$17.12
52-week range	$13.05 - $21.55
50-day moving average	$14.97
200-day moving average	$16.18
Wall St. target price	$26.72
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Nanobiotix S-A shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Nanobiotix S-A stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Nanobiotix S.A by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nanobiotix S-A price performance over time

Historical closes compared with the close of $17.12 from 2021-05-28

1 week (2021-07-15)	N/A
1 month (2021-06-25)	18.89%
3 months (2021-04-26)	6.85%
6 months (2021-01-22)	N/A

1 year (2020-07-22)	N/A
2 years (2019-07-22)	N/A
3 years (2018-07-22)	N/A
5 years (2016-07-22)	N/A

Nanobiotix S-A financials

Revenue TTM	$2.5 million
Gross profit TTM	$2.5 million
Return on assets TTM	-23.94%
Return on equity TTM	-97.99%
Profit margin	0%
Book value	$2.05
Market capitalisation	$480.7 million

TTM: trailing 12 months

Shorting Nanobiotix S-A shares

There are currently 12,561 Nanobiotix S-A shares held short by investors – that's known as Nanobiotix S-A's "short interest". This figure is 0.4% down from 12,613 last month.

There are a few different ways that this level of interest in shorting Nanobiotix S-A shares can be evaluated.

Nanobiotix S-A's "short interest ratio" (SIR)

Nanobiotix S-A's "short interest ratio" (SIR) is the quantity of Nanobiotix S-A shares currently shorted divided by the average quantity of Nanobiotix S-A shares traded daily (recently around 1631.2987012987). Nanobiotix S-A's SIR currently stands at 7.7. In other words for every 100,000 Nanobiotix S-A shares traded daily on the market, roughly 7700 shares are currently held short.

To gain some more context, you can compare Nanobiotix S-A's short interest ratio against those of similar companies.

• Moderna (MRNA.US): 1.3
• Arrowhead Pharmaceuticals (ARWR.US): 4.1
• Regulus Therapeutics (RGLS.US): 0.85

However Nanobiotix S-A's short interest can also be evaluated against the total number of Nanobiotix S-A shares, or, against the total number of tradable Nanobiotix S-A shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nanobiotix S-A's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Nanobiotix S-A shares in existence, roughly 0 shares are currently held short) or 0.0004% of the tradable shares (for every 100,000 tradable Nanobiotix S-A shares, roughly 0 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Nanobiotix S-A.

Find out more about how you can short Nanobiotix S-A stock.

Nanobiotix S-A share dividends

We're not expecting Nanobiotix S-A to pay a dividend over the next 12 months.

Nanobiotix S-A share price volatility

Over the last 12 months, Nanobiotix S-A's shares have ranged in value from as little as $13.05 up to $21.55. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nanobiotix S-A's is 2.2168. This would suggest that Nanobiotix S-A's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put Nanobiotix S-A's beta into context you can compare it against those of similar companies.

• Moderna (MRNA.US): 1.4749
• Arrowhead Pharmaceuticals (ARWR.US): 1.2546
• Regulus Therapeutics (RGLS.US): 2.2622

Nanobiotix S-A overview

Nanobiotix S. A. , a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. The company develops NanoXray products to help patients receiving radiotherapy by enhancing the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. It offers NBTXR3, a sterile aqueous suspension of functionalized crystalline hafnium oxide nanoparticles used for the treatment of solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, and non-small cell lung cancer. Nanobiotix S. A.

Frequently asked questions

What percentage of Nanobiotix S-A is owned by institutions?
Currently 13.979% of Nanobiotix S-A shares are held by institutions. How many people work for Nanobiotix S-A?
Latest data suggests 88 work at Nanobiotix S-A. When does the fiscal year end for Nanobiotix S-A?
Nanobiotix S-A's fiscal year ends in December. Where is Nanobiotix S-A based?
Nanobiotix S-A's address is: 60 rue de Wattignies, Paris, France, 75012